Oramed Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.06.24	Oramed Board Authorizes Stock Repurchase Plan - Quick Facts (RTTNews)
22.09.23	Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holdin... (PR Newswire)
12.01.23	Oramed Pharma Plunges After Its Diabetes Drug Failed In Late-stage Study (RTTNews)
12.01.23	Pre-market Movers: ORMP, XPON, YTEN, KNOP, OPGN… (RTTNews)
12.01.23	Oramed To Stop Oral Insulin Clinical Activities For Type 2 Diabetes Following Disappointing Results (RTTNews)
13.09.22	Oramed Gets Positive Mid-stage Results From NASH Trial With ORMD-0801 (RTTNews)
03.05.22	Oramed Completes Patient Enrollment in Pivotal Phase 3 Oral Insulin Study ORA-D-013-1 (PR Newswire)
29.12.21	MyMD : Oravax Medical Signs Deal For Initial Pre-Purchase Of 10 Mln Doses Of Oral COVID-19 Vaccine (RTTNews)
29.12.21	Oramed Gets Pre-purchase Order From Tan Thanh For Initial 10 Mln Doses Of Oral Covid-19 Vaccine (RTTNews)
23.11.21	Pre-market Movers: PTPI, ISPC, QLGN, AADI, BTB… (RTTNews)
18.11.21	Oramed Unit, Genomma Lab Join To Commercialize Oral COVID-19 Vaccine Candidate In Mexico (RTTNews)
10.08.21	MyMD Pharma's Unit Oravax Medical Preparing To Commence Clinical Trials For Oral COVID-19 Vaccine (RTTNews)
09.08.21	Oramed to Present at Canaccord Genuity's 41st Annual Growth Conference (PR Newswire)
05.08.21	Oravax to Present Keynote Talk on Oral COVID-19 Vaccine at the Arena International Vaccines Virtual Conference 2021 (PR Newswire)
29.07.21	Oramed Pharmaceuticals Appoints Chief Commercial Officer (PR Newswire)
21.07.21	Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial (PR Newswire)
22.06.21	Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes (PR Newswire)
08.06.21	Oramed Reaches 50% Enrollment in Phase 3 Oral Insulin Study (PR Newswire)
19.03.21	Oramed Pharma To Form JV To Develop Oral COVID-19 Vaccines - Quick Facts (RTTNews)
30.11.20	Pre-market Movers In Healthcare Sector: ORMP, VSTM, MRNA, COCP, SYBX... (RTTNews)
27.02.20	CODX On Fire, MNLO Plunges On Serlopitant Data, VIR Enters COVID-19 Vaccine Race (RTTNews)
03.12.19	Healthcare Stocks That Hit New Highs (XENE, AQST, DRNA...) (RTTNews)
03.12.19	KOD Dazzles, GLMD On Watch, DRIO Turns Heads… (RTTNews)
19.06.18	Oramed to be Added to Russell Microcap® Index (PR Newswire)
12.06.18	Oramed to Present at the American Diabetes Association 78th Scientific Sessions (PR Newswire)
31.05.18	OGEN Plays It Safe, MOTS Awaits Data In Q4, EXAS Soars On ACS New Guideline (RTTNews)
30.05.18	Oramed Patent Allowed in the US for Oral Administration of Proteins (PR Newswire)
07.05.18	Oramed to Present at Conferences in May (PR Newswire)
23.04.18	Oramed Initiates Its 90-Day Pivotal Dose-Ranging Clinical Study for Oral Insulin (PR Newswire)
16.04.18	JFrog Launches Xray 2.0 with High Availability to Bolster DevSecOps (PR Newswire)
02.04.18	American Financial Benefits Center Advocates for Regular Money Talks Before Marriage and Beyond (PR Newswire)
27.03.18	Oramed to Present at H.C. Wainwright Annual Global Life Sciences Conference (PR Newswire)
15.03.18	Oramed to Present at Oppenheimer's Annual Healthcare Conference (PR Newswire)
28.02.18	Oramed Adds Two New Members to its Scientific Advisory Board (PR Newswire)
20.02.18	Oramed to Present at the CODHy 6th World Congress on Diabetes, Obesity and Hypertension (PR Newswire)
06.02.18	Oramed to Present at BIO CEO Investor Conference (PR Newswire)
19.01.18	Oramed Pharmaceuticals' CEO Issues Letter to Shareholders (PR Newswire)
15.11.17	FDA Nod For AZN's Asthma Drug, Genmab Revises Outlook, NBY Disappoints (RTTNews)
14.11.17	Oramed Receives Regulatory Approval to Conduct Clinical Study for Treatment of NASH with its Oral Insulin Capsule (PR Newswire)
31.10.17	Oramed Granted Broad Composition of Matter Patent in Europe for Oral Proteins (PR Newswire)
17.10.17	Endocrinology, Diabetes and Metabolism Journal Publishes Scientific Paper Authored by Oramed Scientists (PR Newswire)
25.09.17	Oramed to Present at the Disruptive Growth Showcase Conference (PR Newswire)
05.09.17	Oramed Announces Successful Meeting with FDA for Oral Insulin (PR Newswire)
29.08.17	Oramed to Present at the Rodman & Renshaw Global Investment Conference (PR Newswire)
18.07.17	Oramed Appoints Dr. Simon Bruce as Vice President of Medical Affairs (PR Newswire)
12.07.17	Oramed to Present at BIT'S 5th World Congress of Diabetes on July 13, 2017 (PR Newswire)
12.07.17	ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE (RTTNews)
11.07.17	Oramed Announces End-of-Phase 2 Meeting with FDA to Initiate Phase 3 Program (PR Newswire)
05.07.17	Oramed Announces Dual-Listing on Tel Aviv Stock Exchange (PR Newswire)
27.06.17	Oramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog Capsule (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Oramed Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten